Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer

1 Sept 2021

Abstract excerpt

Purpose Bladder cancer (BLCA) is one of the most common cancers worldwide. In a large proportion of BLCA patients, disease recurs and/or progress after resection, which remains a major clinical issue in BLCA management. Therefore, it is vital to identify prognostic biomarkers for treatment stratification. We investigated the efficiency of CpG methylation for the potential to be a prognostic biomarker for patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34540821
DOI: 10.3389/fcell.2021.642650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder CancerPMID 34540821Read ↗

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroupsSemantic proximity Read ↗

A six-gene prognostic model predicts overall survival in bladder cancer patientsSemantic proximity Read ↗

Exploring prognostic DNA methylation genes in bladder cancer: a comprehensive analysisSemantic proximity Read ↗

Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation ProfileSemantic proximity Read ↗

Establishment of a CIMP-associated prognostic model for bladder cancerSemantic proximity Read ↗

Multi-Omics Analysis Identifies the Heterogeneity and Prognosis in Bladder CancerSemantic proximity Read ↗

Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder CancerSemantic proximity Read ↗

ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatmentSemantic proximity Read ↗

Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancerSemantic proximity Read ↗

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder CancerSemantic proximity Read ↗

Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine SedimentsSemantic proximity Read ↗

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.